Franz B. Humer
Director · Allogene Therapeutics, Inc.
- 2024
- Jun 23, 2026
- 2
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Franz B. Humer files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- David D. Chang - $289K in ALLO purchases and sales in the last 12 months
- Zachary Roberts - $104K in ALLO purchases and sales in the last 12 months
- Earl Martin Douglas - $103K in ALLO purchases and sales in the last 12 months
- Geoffrey M. Parker - $88K in ALLO purchases and sales in the last 12 months
- Benjamin Machinas Beneski - $52K in ALLO purchases and sales in the last 12 months
- Annie Yoshiyama - $29K in ALLO purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Franz B. Humer?
Franz B. Humer is a corporate insider, tracked as Director of Allogene Therapeutics, Inc. (ALLO). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Franz B. Humer last file a Form 4?
The most recent primary Form 4 on record is dated 23 June 2026, one of 2 filings going back to 2024.
Has Franz B. Humer been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($20K) across all tracked filings.
